Key Decisions and Approvals
The Board of Directors approved the following businesses:
1. Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026 as recommended by the Audit Committee
Meeting Details
The Board meeting commenced at 5:00 PM and concluded at 6:00 PM on July 22, 2026.
Financial Results Overview
Standalone Financial Results (₹ in Lakhs):
- Revenue from operations: ₹28,401.90 (Q1 FY27) vs ₹15,800.38 (Q1 FY26) - 80% increase
- Other income: ₹1,675.71 (Q1 FY27) vs ₹674.71 (Q1 FY26)
- Total income: ₹30,077.60 (Q1 FY27) vs ₹16,475.09 (Q1 FY26)
- Profit before tax: ₹4,839.56 (Q1 FY27) vs ₹1,653.03 (Q1 FY26)
- Tax expense: ₹1,245.09 (Q1 FY27) vs ₹453.99 (Q1 FY26)
- Profit for the period: ₹3,594.47 (Q1 FY27) vs ₹1,199.04 (Q1 FY26) - 200% increase
- Basic EPS: ₹8.24 (Q1 FY27) vs ₹2.75 (Q1 FY26)
- Diluted EPS: ₹8.24 (Q1 FY27) vs ₹2.75 (Q1 FY26)
Consolidated Financial Results (₹ in Lakhs):
- Revenue from operations: ₹28,401.90 (Q1 FY27)
- Other income: ₹1,675.71 (Q1 FY27)
- Total income: ₹30,077.60 (Q1 FY27)
- Profit before tax: ₹4,609.62 (Q1 FY27)
- Tax expense: ₹1,218.62 (Q1 FY27)
- Profit for the period: ₹3,391.40 (Q1 FY27)
- Profit attributable to owners: ₹3,415.18 (Q1 FY27)
- Basic EPS: ₹7.60 (Q1 FY27)
- Diluted EPS: ₹7.63 (Q1 FY27)
Segment-wise Performance (Standalone)
Quarter Ended June 30, 2026 (₹ in Lakhs):
- Chemicals Segment: Revenue ₹27,417.47, Profit ₹3,751.72
- Solar Power Segment: Revenue ₹829.65, Profit ₹488.76
- Pharma Segment: Revenue ₹70.25, Loss ₹(114.32)
- Others: Revenue ₹84.61, Profit ₹43.39
Auditor Review
Statutory auditors Sarda & Pareek LLP (FRN no. 109262W/W100673) conducted a limited review of both standalone and consolidated financial results. Partner Gaurav Sarda (Membership No. 110208) issued the review reports concluding that the financial results give a true and fair view and contain no material misstatements.
Subsidiary Information
The consolidated results include 6 subsidiaries:
1. Bhageria & Jajodia Pharmaceuticals Private Limited
2. Hikaru Solar Power Private Limited
3. New Ahilyanagar Solar Private Limited
4. Rahuri Cleantech Private Limited
5. Salasar Renewables Private Limited
6. Bhageria Rare Earth Minerals Private Limited
These subsidiaries contributed total revenue of ₹312.25 lakhs and net loss of ₹(147.44) lakhs for the quarter.
Additional Information
The financial results will be published in newspapers as per Regulation 47(1)(b) of SEBI (LODR) Regulations, 2015. The full results are available on the company's website (www.bhageriagroup.com) and stock exchange websites (www.bseindia.com, www.nseindia.com).